How to Export Medicines From India: The Two Routes (2026 Guide)

Exporting medicine from India is not one process. It is two, and which one you are in depends entirely on a single question: does the destination country require the product to be registered before it can be imported?

Get that question right and everything else follows. Get it wrong and you will spend eight months on a dossier for a market that did not need one, or ship a consignment that gets held at the port because it needed one.

The two routes

Route 1 — Regulated markets: registration required

Most countries require a pharmaceutical product to be registered with their own drug authority before it can be imported and sold. The dossier they want names the manufacturing site, and the applicant has to be — or be backed by — the manufacturer.

They will ask for some combination of:

• CoPP (Certificate of Pharmaceutical Product) — the WHO-format certificate issued by the drug regulator, which names the manufacturer and the site
• WHO-GMP site certificate for the plant that makes it
• Free Sale Certificate
• Product dossier, stability data, method validation, specifications
• Sometimes a site inspection

Every one of those documents points at a plant. A marketing company cannot produce them, because it does not have a plant to point at. In this route the manufacturer has to be in the transaction, and the product is made to order against your registered specification and pack.

Timelines run in months, sometimes over a year. This is a business you enter deliberately, not opportunistically.

Route 2 — Markets with no registration requirement

Some destinations do not require product registration for import, or route it through tender, institutional or aid channels where the requirement sits elsewhere. Here you are not building a dossier — you are shipping goods.

That means ready stock from an existing range can go, subject to the destination's actual rules and the usual export documentation. Faster, lower commitment, and it suits an importer who wants product now rather than a registered brand in three quarters.

How to find out which route you are in

Ask the importer or the destination's drug regulator one question: does this product require registration before import, and does it require a CoPP?

• Yes to either → Route 1. The manufacturer must be named. Made to order.
• No to both → Route 2. Ready stock is possible.

Do not guess this from a list of "regulated markets" on a blog. Requirements change, they differ by product category, and the only answer that counts is the destination's.

What you need in India, either way

• IEC — Import Export Code from DGFT
• Pharmexcil registration — RCMC from the Pharmaceuticals Export Promotion Council
• Drug licence and GST
• Invoice, packing list, shipping bill, certificate of analysis per batch
• Destination-specific labelling — language, pack, and their declarations, not ours

The check that decides your product list

Before any of this: which dosage forms can the plant actually make?

A WHO-GMP site certificate names one plant and lists the exact dosage forms it may produce. A site certified for tablets, capsules, external preparations and oral liquids cannot legally make your injectable or your eye drop — beta-lactams need physically segregated premises by regulation, sterile forms need sterile lines.

So the certificate shapes your export catalogue before your ambition does. Read the dosage-form table before you promise an importer anything.

Which Vibcare company you need — and they are different companies

If registration or a CoPP is required → Vibcare Healthcare

Vibcare Healthcare Private Limited is the manufacturing company — a separate legal entity under the same ownership as Vibcare Pharma, with its own plant, licences and website. It holds the WHO-GMP site certificate and the Pharmexcil registration, and it is the only one of the two that can appear on a dossier as manufacturer.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals.

Certified for four dosage forms: tablets, capsules and external preparations — all non beta-lactam — and oral liquids. It does not make beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, or ayurvedic products, because it is not certified for them. If your export list needs those forms, tell us early and we will say so rather than take the enquiry.

Product is made to order against your registered specification and pack.

If no registration is required → Vibcare Pharma, from ready stock

Where the destination does not require registration, Vibcare Pharma can supply from its existing range — 1,500+ products across 11+ divisions, already made, already packed. No dossier, no development cycle, subject to the destination's actual import rules and documentation.

That suits an importer who wants product moving now rather than a registered brand in three quarters.

The honest advice

Do not start with the product. Start with the destination's rules. Almost every failed pharma export begins with someone falling in love with a price list before they knew whether the goods could legally land.

Ask the importer for the registration requirement in writing. Then come and talk about products.

Frequently asked questions

How do you export medicines from India?

First establish whether the destination requires product registration or a CoPP. If it does, the manufacturer must be named on the dossier and the product is made to order. If it does not, ready stock can be shipped. In India you need an IEC from DGFT, Pharmexcil RCMC registration, a drug licence and GST.

What is a CoPP and when do you need one?

A Certificate of Pharmaceutical Product, issued in WHO format by the drug regulator, naming the product and its manufacturing site. Most countries require it before registering an imported medicine. Because it names a plant, only a manufacturer can obtain one — a marketing company cannot.

What is the procedure for export of pharmaceutical products from India?

Confirm the destination's registration requirement; obtain IEC from DGFT and Pharmexcil RCMC; hold a valid drug licence and GST; if registration is needed, compile the dossier with CoPP, WHO-GMP certificate and stability data through the manufacturer; then invoice, packing list, shipping bill and per-batch certificate of analysis, with destination-specific labelling.

Can a pharma marketing company export medicine, or only a manufacturer?

Where the destination requires registration or a CoPP, the manufacturer must be in the transaction, because every one of those documents names a plant. Where no registration is required, a marketing company can supply ready stock subject to the destination's import rules and export documentation.

Which documents are needed to export medicines from India?

IEC from DGFT, Pharmexcil RCMC, drug licence, GST, commercial invoice, packing list, shipping bill and a certificate of analysis for each batch. Regulated destinations additionally require a CoPP, the WHO-GMP site certificate, a Free Sale Certificate and a full product dossier.